glp 1 agonist black box warning Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning FDA Adds New Warning to

BMJ (2017) 359:j4849

Others may argue that for people who have a large percentage of weight to lose and struggle getting started with a more foundational approach to weight loss, drugs like Wegovy can give them a jump start or help get their foot in the door on healthier habits by helping them control their appetite in the beginning

Data Synthesis Retained gastric contents at the time of upper gastrointestinal endoscopy are found more frequently with GLP-1 RAs but rarely are associated with pulmonary aspiration

& Zhao, S

Even plans that do cover obesity treatment often require extensive documentation including BMI records, documentation of previous weight loss attempts, evidence of weight-related health conditions, and detailed justification from your physician

Yet treatment options remain frustratingly limited - and for many, inadequate